BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23485545)

  • 1. Re: Effect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease.
    Balta S; Cakar M; Demirkol S; Balta I; Kurt O
    Iran J Kidney Dis; 2013 Mar; 7(2):166-7. PubMed ID: 23485545
    [No Abstract]   [Full Text] [Related]  

  • 2. Shall we stop or continue angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prior to using contrast agents?
    Ganji MR
    Iran J Kidney Dis; 2012 Nov; 6(6):397-400. PubMed ID: 23146974
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease.
    Spatz C; Saadulla L; Lapsiwala A; Parhizgar A; Ghahramani N
    Iran J Kidney Dis; 2012 Nov; 6(6):432-6. PubMed ID: 23146980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of renin-angiotensin-system blockers on contrast-medium-induced acute kidney injury after coronary angiography.
    Goo JJ; Kim JJ; Kang JH; Kim KN; Byun KS; Kim MK; Kim TI
    Korean J Intern Med; 2014 Mar; 29(2):203-9. PubMed ID: 24648803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of renin-angiotensin-aldosterone system-blocking agents on the risk of contrast-induced acute kidney injury: a prospective study and meta-analysis.
    Peng F; Su J; Lin J; Niu W
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):262-8. PubMed ID: 25502308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in contrast-induced nephropathy.
    Zhou L; Duan S
    Kidney Blood Press Res; 2013; 38(2-3):165-71. PubMed ID: 24686005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
    Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relation between renin-angiotensin-aldosterone system blockade and contrast-induced nephropathy: an unresolved issue.
    Balta S; Aparci M
    Cardiology; 2015; 130(1):1-3. PubMed ID: 25428132
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal outcomes in the ONTARGET study.
    Gallieni M; Cozzolino M; Brancaccio D; Giovannini M
    Lancet; 2008 Dec; 372(9655):2019; author reply 2020-1. PubMed ID: 19070732
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment with patiromer decreases aldosterone inĀ patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Weir MR; Bakris GL; Gross C; Mayo MR; Garza D; Stasiv Y; Yuan J; Berman L; Williams GH
    Kidney Int; 2016 Sep; 90(3):696-704. PubMed ID: 27350174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of renin-angiotensin-aldosterone system blockade on contrast-induced nephropathy: a meta-analysis of 12 studies with 4,493 patients.
    Jo SH; Lee JM; Park J; Kim HS
    Cardiology; 2015; 130(1):4-14. PubMed ID: 25428235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute kidney injury and death associated with renin angiotensin system blockade in cardiothoracic surgery: a meta-analysis of observational studies.
    Yacoub R; Patel N; Lohr JW; Rajagopalan S; Nader N; Arora P
    Am J Kidney Dis; 2013 Dec; 62(6):1077-86. PubMed ID: 23791246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of effect of renin-angiotensin-aldosterone system blockers on contrast-induced nephropathy.
    Wang W; Qu W; Sun D; Liu X
    J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320919587. PubMed ID: 32370685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
    Onuigbo MA
    Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity of hydration changes the role of renin-angiotensin-aldosterone system blockers in contrast-induced nephropathy risk after coronary catheterisation in patients with chronic kidney disease.
    Guo XS; Wu DX; Bei WJ; Li HL; Wang K; Zhou YL; Duan CY; Chen SQ; Lian D; Li LW; Liu Y; Tan N; Chen JY
    J Renin Angiotensin Aldosterone Syst; 2017; 18(2):1470320317708894. PubMed ID: 28490226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial.
    Kiski D; Stepper W; Brand E; Breithardt G; Reinecke H
    Nephrol Dial Transplant; 2010 Mar; 25(3):759-64. PubMed ID: 19903660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete inhibition of the renin-angiotensin-aldosterone system; where do we stand?
    Chen SS; Seliger SL; Fried LF
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):449-55. PubMed ID: 25014549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal insufficiency caused by medicines, diagnostic processes, toxins].
    Szegedi J
    Orv Hetil; 2007 Jan; 148(3):99-103. PubMed ID: 17289612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal safety and angiotensin II blockade medications in patients undergoing non-emergent coronary angiography: a randomized controlled study.
    Wolak T; Aliev E; Rogachev B; Baumfeld Y; Cafri C; Abu-Shakra M; Novack V
    Isr Med Assoc J; 2013 Nov; 15(11):682-7. PubMed ID: 24511648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study.
    Rim MY; Ro H; Kang WC; Kim AJ; Park H; Chang JH; Lee HH; Chung W; Jung JY
    Am J Kidney Dis; 2012 Oct; 60(4):576-82. PubMed ID: 22658321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.